ANDA 208679, held by Mem Sloan-Kettering. Fludeoxyglucose F-18.
As of Nov 16, 2026, ANDA 208679 (Fludeoxyglucose F18), held by Mem Sloan-Kettering, was first approved by FDA on Dec 8, 2016, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 8, 2016 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Fludeoxyglucose F1820-300mCi/ML ยท injectable;intravenous | Fludeoxyglucose F-18 | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters